Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LEXINGTON, Mass., May 20, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
-
SCHAUMBURG, Ill., May 18, 2015 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB:WCUI), today announced the appointment of Seth B. Forman, MD as Medical Director of Psoria-Shield, Inc. (PSI). Dr....
-
SAN DIEGO, May 12, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
-
Continued Pipeline Progress in Partnered and Proprietary Programs Conference Call/Webcast Today at 4:30 p.m. Eastern Time BURNABY, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Xenon...
-
REDWOOD CITY, CA--(Marketwired - May 12, 2015) - Autonomic Technologies, Inc. (ATI), Entwickler und Hersteller von Pulsante™, einem Mikrostimulator für die Behandlung schwerer...
-
REDWOOD CITY, CA--(Marketwired - May 12, 2015) - Autonomic Technologies™, Inc. (ATI™), developer and manufacturer of Pulsante™, a microstimulator to treat severe headaches, today...
-
VERY STRONG START TO 2015: 22% GROWTH OF GROUP REVENUES, MAINLY DRIVEN BY EVT EXECUTE MAJOR MULTI-COMPONENT STRATEGIC ALLIANCE WITH SANOFI CLOSED FULL-YEAR REVENUE GUIDANCE...
-
SOUTH SAN FRANCISCO, May 11, 2015 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR)...
-
NEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its second fiscal quarter ended March...
-
BURNABY, British Columbia, May 7, 2015 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2015 first...